We use cookies to better understand how you use our site and to improve your experience by personalizing content. Please review our updated Privacy Policy and Terms of Use. If you accept the use of cookies, please click the "I accept" button.I acceptI declineX
Skip navigational links

Agency for Healthcare Research and Quality Releases a Report on Medication Therapy Management Programs


Email Alert

March 20, 2007

The Agency for Healthcare Research and Quality (AHRQ) Effective Health Care Program released a new research report titled Survey of Medicare Part D Plans' Medication Therapy Management Programs (Report). The Report describes and summarizes a survey about enrollment criteria and benefit design for Medication Therapy Management (MTM) programs offered throughout the United States under a provision of the Medicare Prescription Drug, Improvement and Modernization Act of 2003.

The Report concluded that MTM programs are highly variable and that definitive evidence supporting many of the more common interventions is lacking. The most frequently provided MTM services were patient education (75.0%), patient adherence programs (70.0%), and medication review (60.0%). Seventy health insurance plans, covering 12.1 million Medicare enrollees and representing 21 distinct MTM programs, completed surveys. The health insurance plans that responded to the survey represent at least 12.1 million Medicare enrollees out of a total of 20.7 million or approximately at least 58.5% of the eligible population.

Access the Survey of Medicare Part D Plans' Medication Therapy Management Programs.

We would like to thank Caroline Wade Blankenship (Miller Stratvert PA, Albuquerque, NM) for providing this email alert.

© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105